NCT07539779 2026-04-20
Luspatercept in Preventing Poor Erythroid Engraftment for Hematological Malignancies With Moderate to Severe Myelofibrosis
Nanfang Hospital, Southern Medical University
Phase 2/3 Not yet recruiting
Clinical Trials
5 trialsNCT05732961 2025-12-10
Luspatercept for Anemia in Lower Risk MDS or Non-proliferative MDS/MPN Neoplasms
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Recruiting
NCT06927232 2025-04-15
AZA+Lus VS AZA Monotherapy in HR-MDS
Peking Union Medical College Hospital
Phase 3 Not yet recruiting
NCT05005182 2024-09-19
Luspatercept With or Without Hydroxyurea for the Treatment of Myelodysplastic/Myeloproliferative Neoplasms With Ring Sideroblasts and Thrombocytosis or Unclassifiable With Ring Sideroblasts
Mayo Clinic
Phase 2 Terminated
NCT06254781 2024-02-12
Luspatercept in Metastatic AGCT of the Ovary
University Health Network, Toronto
Phase NA Completed